Atlas Trials

Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue

Clinical trial NCT03423173 · COMPLETED

Trial details

NCT number
NCT03423173
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dengue Fever
Start date
2018-02-12
Primary completion
2018-08-03
Enrollment
923

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.